Pharmacokinetics, Pharmacodynamics, and Immunogenicity of Belatacept in Adult Kidney Transplant Recipients

BACKGROUND AND OBJECTIVES: Belatacept is a first-in-class, selective co-stimulation blocker recently approved for the prophylaxis of organ rejection in adult kidney transplant recipients. The objective of this study was to report the pharmacokinetics, pharmacodynamics, and immunogenicity of belatace...

Descripción completa

Detalles Bibliográficos
Autores principales: Shen, Jinshan, Townsend, Robert, You, Xiaoli, Shen, Yun, Zhan, Ping, Zhou, Zexun, Geng, Dong, Wu, Dianna, McGirr, Nadia, Soucek, Kathleen, Proszynski, Elizabeth, Pursley, Janice, Masson, Eric
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2013
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3899455/
https://www.ncbi.nlm.nih.gov/pubmed/24217983
http://dx.doi.org/10.1007/s40261-013-0153-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3899455/
https://www.ncbi.nlm.nih.gov/pubmed/24217983
http://dx.doi.org/10.1007/s40261-013-0153-2

Ejemplares similares